Predicting Kidney Transplantation Outcomes from Donor and Recipient Characteristics at Time Zero: Development of a Mobile Application for Nephrologists

(1) Background: We report on the development of a predictive tool that can estimate kidney transplant survival at time zero. (2) Methods: This was an observational, retrospective study including 5078 transplants. Death-censored graft and patient survivals were calculated. (3) Results: Graft loss was...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical medicine Vol. 13; no. 5; p. 1270
Main Authors Pérez Valdivia, Miguel Ángel, Calvillo Arbizu, Jorge, Portero Barreña, Daniel, Castro de la Nuez, Pablo, López Jiménez, Verónica, Rodríguez Benot, Alberto, Mazuecos Blanca, Auxiliadora, de Gracia Guindo, Mª Carmen, Bernal Blanco, Gabriel, Gentil Govantes, Miguel Ángel, Bedoya Pérez, Rafael, Rocha Castilla, José Luis
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 23.02.2024
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:(1) Background: We report on the development of a predictive tool that can estimate kidney transplant survival at time zero. (2) Methods: This was an observational, retrospective study including 5078 transplants. Death-censored graft and patient survivals were calculated. (3) Results: Graft loss was associated with donor age (hazard ratio [HR], 1.021, 95% confidence interval [CI] 1.018-1.024, < 0.001), uncontrolled donation after circulatory death (DCD) (HR 1.576, 95% CI 1.241-2.047, < 0.001) and controlled DCD (HR 1.567, 95% CI 1.372-1.812, < 0.001), panel reactive antibody percentage (HR 1.009, 95% CI 1.007-1.011, < 0.001), and previous transplants (HR 1.494, 95% CI 1.367-1.634, < 0.001). Patient survival was associated with recipient age (> 60 years, HR 5.507, 95% CI 4.524-6.704, < 0.001 vs. < 40 years), donor age (HR 1.019, 95% CI 1.016-1.023, < 0.001), dialysis vintage (HR 1.0000263, 95% CI 1.000225-1.000301, < 0.01), and male sex (HR 1.229, 95% CI 1.135-1.332, < 0.001). The C-statistics for graft and patient survival were 0.666 (95% CI: 0.646, 0.686) and 0.726 (95% CI: 0.710-0.742), respectively. (4) Conclusions: We developed a mobile app to estimate survival at time zero, which can guide decisions for organ allocation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm13051270